MYO: Q3 2025 revenue up 10% to $10.1M; gross margin down, net loss widens, guidance maintained

Quartr

Q3 2025 revenue rose 10% year-over-year to $10.1 million, with record O&P channel performance and a strong patient pipeline. Gross margin declined to 63.8%, and net loss widened to $3.7 million. Full-year revenue guidance of $40–$42 million is reiterated.

Original document: Myomo Inc. [MYO] SEC 8-K Current Report — Nov. 10 2025

Disclaimer

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Risk Warnings and Disclaimers

You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.

Add to Favorites

MYO: Q3 revenue up 10% year-over-year, but net losses widened amid higher costs and margin pressure

Quartr

Myomo

+3.65%

Revenue grew 10% year-over-year for Q3 and 44% for the nine months, but net losses widened due to higher operating expenses and lower gross margins. Liquidity remains strong following recent equity and debt financings, though risks include reliance on Medicare reimbursement and increased lead generation costs.

Original document: Myomo Inc. [MYO] SEC 10-Q Quarterly Report — Nov. 10 2025

Disclaimer

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Risk Warnings and Disclaimers

Add to Favorites

MYO: Q3 revenue up 10% to $10.1M, pipeline and O&P channel grew, guidance reaffirmed

Quartr

Myomo

+3.65%

Q3 2025 revenue rose 10% to $10.1M, driven by record international and O&P channel growth. Gross margin declined due to higher costs, but the patient pipeline expanded 32% year-over-year. Full-year guidance of $40–$42M was reiterated, with a focus on operating leverage and diversified revenue streams.

Based on Myomo Inc. [MYO] Q3 2025 Audio Transcript — Nov. 10 2025

Disclaimer

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Risk Warnings and Disclaimers

Add to Favorites

CoreWeave, Occidental, Tyson Foods, and more set to report earnings Monday

Investing.com

DoubleDown Interactive

Earnings season continues, below we highlight companies expected to report earnings the next trading day so you can prepare for the action. Leading the charge on Monday are some significant players across various sectors, including CoreWeave, Occidental Petroleum, Tyson Foods, Monday.com, and Maplebear, offering investors insights into both technology and traditional industries.

Earnings Before the Open:

• Climate Change Crisis I (EVGO): EPS estimate -$0.087, revenue estimate $91.12M

• Global Ship Lease Inc (GSL): EPS estimate $2.37, revenue estimate $184.6M

• Montes Archimedes Acquisition (ROIV): EPS estimate -$0.3176, revenue estimate $5.6M

• Adc Therapeutics SA (ADCT): EPS estimate -$0.3567, revenue estimate $17.98M

• Tyson Foods (TSN): EPS estimate $0.8735, revenue estimate $14.13B

• Treehouse Foods Inc (THS): EPS estimate $0.5659, revenue estimate $851.99M

• Monday (MNDY): EPS estimate $0.8756, revenue estimate $312.31M

• EJF Acquisition (PGY): EPS estimate $0.1814, revenue estimate $335.69M

• Surgery Partners Inc (SGRY): EPS estimate $0.2129, revenue estimate $821.86M

• Apollo Strategic Growth (GBTG): EPS estimate $0.0426, revenue estimate $615.28M

• Silverback Therapeutics Inc (SPRY): EPS estimate -$0.458, revenue estimate $28.56M

• Experience Investment (SRTA): EPS estimate $0.0156, revenue estimate $61.31M

• Telos Corp (TLS): EPS estimate $0.015, revenue estimate $38.53M

• Northern Star Acquisition (BARK): EPS estimate -$0.0216, revenue estimate $103.58M

• Ammo (POWW): EPS estimate -$0.03, revenue estimate $11.23M

• Camtek Ltd (CAMT): EPS estimate $0.811, revenue estimate $125.04M

• Harsco Corp (NVRI): EPS estimate $0, revenue estimate $573.6M

• Motorcar Parts of America (MPAA): EPS estimate $0.5, revenue estimate $198M

• CEVA (CEVA): EPS estimate $0.142, revenue estimate $28.49M

• Maplebear (CART): EPS estimate $0.20, revenue estimate $867.50M

• Lithium Americas NYQ (LAR): EPS estimate -$0.0102, revenue estimate $54.38M

• I.D. Systems (AIOT): EPS estimate -$0.0017, revenue estimate $105.51M

• Blackstone Secured Lending Fund (BXSL): EPS estimate $0.7852, revenue estimate $353.53M

• 908 Devices Inc (MASS): EPS estimate -$0.1425, revenue estimate $13.52M

• Ranger Energy Services (RNGR): EPS estimate $0.2733, revenue estimate $142.2M

• Profrac Holding (ACDC): EPS estimate -$0.4266, revenue estimate $436.22M

• Starwood Property Trust Inc (STWD): EPS estimate $0.4484, revenue estimate $494.03M

• Tower Semiconductor (TSEM): EPS estimate $0.5434, revenue estimate $394.97M

• Lincoln Education (LINC): EPS estimate $0.12, revenue estimate $129.22M

• WhiteHorse Finance (WHF): EPS estimate $0.2904, revenue estimate $18.39M

• Dole (DOLE): EPS estimate $0.175, revenue estimate $2.19B

• Blue Safari Group Acquisition Corp (BTDR): EPS estimate -$0.1636, revenue estimate $150.05M

• Wave Life Sciences Ltd (WVE): EPS estimate -$0.2547, revenue estimate $12.89M

• Perma-Fix Environ (PESI): EPS estimate -$0.1187, revenue estimate $16.25M

• Akebia Ther (AKBA): EPS estimate -$0.036, revenue estimate $52.06M

• Freightcar Americ (RAIL): EPS estimate $0.225, revenue estimate $157.25M

• Townsquare Media LLC (TSQ): EPS estimate $0.17, revenue estimate $111.05M

• Village Farms O (VFF): EPS estimate $0.0187, revenue estimate $56.02M

• China BAK Battery (CBAT): EPS estimate -$0.03, revenue estimate $34.66M

• K92 Mining Inc OTC (KNTNF): EPS estimate $0.2536, revenue estimate $157M

• Compugen Ltd (CGEN): EPS estimate -$0.065, revenue estimate $3.13M

• Kaspi.kz AO ADR (KSPI): EPS estimate $3, revenue estimate $1.64B

• Howard Hughes Corp (HHH): EPS estimate $1.2, revenue estimate $360.7M

• Shiseido Company Ltd (SSDOY): EPS estimate $0.0288, revenue estimate $1.54B

• Exodus Movement (EXOD): EPS estimate $0.0967, revenue estimate $29.52M

• Kamada Ltd (KMDA): EPS estimate $0.09, revenue estimate $45.88M

• Caledonia Mining Cp (CMCL): EPS estimate $0.75, revenue estimate $64M

• Venture Global Inc (VG): EPS estimate $0.53, revenue estimate None

• Sonida Senior Living (SNDA): EPS estimate -$0.76, revenue estimate None

• Hannover Re (HVRRY): EPS estimate $0.9926, revenue estimate $8.26B

• eToro Group Ltd (ETOR): EPS estimate $0.58, revenue estimate None

• BKV (BKV): EPS estimate not available, revenue estimate None

• Antalpha Platform Holding Ltd (ANTA): EPS estimate not available, revenue estimate None

Earnings After the Close:

• Energy Vault Holdings (NRGV): EPS estimate -$0.035, revenue estimate $48.99M

• Plug Power (PLUG): EPS estimate -$0.1256, revenue estimate $187.33M

• CC Neuberger Principal Holdings II (GETY): EPS estimate $0.0225, revenue estimate $241.3M

• TechTarget (TTGT): EPS estimate $0.4463, revenue estimate $62.31M

• Doubledown Interactive Co Ltd (DDI): EPS estimate $0.5967, revenue estimate $84.45M

• TheRealReal Inc (REAL): EPS estimate -$0.0713, revenue estimate $169.04M

• Bally’s (BALY): EPS estimate -$0.3519, revenue estimate $632.5M

• Occidental Petro (OXY): EPS estimate $0.504, revenue estimate $6.76B

• Pubmatic Inc (PUBM): EPS estimate -$0.2154, revenue estimate $63.97M

• Motion Acquisition (DCGO): EPS estimate -$0.122, revenue estimate $69.96M

• Imprimis Pharmaceuticals Inc (HROW): EPS estimate $0.2413, revenue estimate $73.69M

• Gevo (GEVO): EPS estimate -$0.0395, revenue estimate $37.03M

• Rigetti Computing Inc (RGTI): EPS estimate -$0.0456, revenue estimate $2.17M

• Health Catalyst (HCAT): EPS estimate $0.0629, revenue estimate $75.9M

• Belite Bio ADR (BLTE): EPS estimate -$0.4975, revenue estimate $0.00

• Hallador Energy C (HNRG): EPS estimate $0.075, revenue estimate $104.14M

• Thunder Bridge A (RPAY): EPS estimate $0.2137, revenue estimate $76.93M

• Viant Technology (DSP): EPS estimate $0.0488, revenue estimate $52.07M

• Kaltura (KLTR): EPS estimate -$0.006, revenue estimate $43.27M

• Ikonics Corp (WULF): EPS estimate -$0.047, revenue estimate $57.4M

• Green Dot Corp (GDOT): EPS estimate -$0.0733, revenue estimate $484.85M

• Tidewater Inc. (TDW): EPS estimate $0.6194, revenue estimate $332.57M

• Alcobra Ltd (ARCT): EPS estimate $5.53, revenue estimate $279.77M

• Identive Group (INVE): EPS estimate -$0.24, revenue estimate $5.77M

• Jamf Holding (JAMF): EPS estimate $0.2331, revenue estimate $177.16M

• Natural Gas Services Group Inc (NGS): EPS estimate $0.3233, revenue estimate $43.25M

• Chegg Inc (CHGG): EPS estimate -$0.0625, revenue estimate $76.3M

• Radiant Logistics Inc (RLGT): EPS estimate $0.12, revenue estimate $235M

• Bain Capital Specialty Finance (BCSF): EPS estimate $0.4511, revenue estimate $68.5M

• Depomed (ASRT): EPS estimate -$0.0867, revenue estimate $27.02M

• Ambac Financial Group Inc (AMBC): EPS estimate -$0.23, revenue estimate $27.46M

• Quest Resou (QRHC): EPS estimate $0.08, revenue estimate $77.56M

• ON24 (ONTF): EPS estimate $0.0069, revenue estimate $33.72M

• Dice Holdings Inc (DHX): EPS estimate $0.0267, revenue estimate $31.72M

• Cannae (CNNE): EPS estimate -$0.285, revenue estimate $107.55M

• Si Bone Inc (SIBN): EPS estimate -$0.1663, revenue estimate $46.67M

• American Public Education (APEI): EPS estimate $0.08, revenue estimate $160.1M

• US Auto Parts Network (PRTS): EPS estimate -$0.145, revenue estimate $142.03M

• Quanterix (QTRX): EPS estimate -$0.4648, revenue estimate $38.18M

• GigCapital4 (BBAI): EPS estimate -$0.05, revenue estimate $31.82M

• TransAct Technolo (TACT): EPS estimate -$0.05, revenue estimate $12.25M

• Myomo Inc (MYO): EPS estimate -$0.1075, revenue estimate $9.57M

• New Providence Acquisition Corp N (ASTS): EPS estimate -$0.2069, revenue estimate $21.87M

• Theravance Biopharma Inc (TBPH): EPS estimate -$0.1335, revenue estimate $19.27M

• Red Robin Gourmet (RRGB): EPS estimate -$0.6775, revenue estimate $256.75M

• iHeartMedia A (IHRT): EPS estimate $0.02, revenue estimate $975.29M

• Laird Superfood Inc (LSF): EPS estimate -$0.0433, revenue estimate $14.13M

• Ascend Wellness OTC (AAWH): EPS estimate -$0.0698, revenue estimate $128.74M

• Virtra Systems Inc (VTSI): EPS estimate $0.0562, revenue estimate $7.49M

• Capricor Therap (CAPR): EPS estimate -$0.537, revenue estimate $600K

• Apt Inv Manage (AIV): EPS estimate -$0.11, revenue estimate $56.09M

• Vaalco Energy Inc (EGY): EPS estimate -$0.02, revenue estimate $74.3M

• Kayne Anderson BDC (KBDC): EPS estimate $0.45, revenue estimate None

• Braskem (BAK): EPS estimate -$0.4157, revenue estimate $3.33B

• Sangoma Tech NAQ (SANG): EPS estimate -$0.03, revenue estimate $59M

• Yalla Group Ltd (YALA): EPS estimate not available, revenue estimate $89.3M

• Sabesp (SBS): EPS estimate $0.2971, revenue estimate $1.3B

• Mineralys Therapeutics (MLYS): EPS estimate -$0.96, revenue estimate None

• Atlantic Acquisition (HFFG): EPS estimate $0.09, revenue estimate $306.19M

• Natural Resources Inc (INR): EPS estimate $0.67, revenue estimate None

• Health In Tech (HIT): EPS estimate $0.01, revenue estimate None

• FTAC Emerald Acquisition (FLD): EPS estimate -$0.18, revenue estimate $12.07M

• CoreWeave (CRWV): EPS estimate -$0.00, revenue estimate None

• StandardAero (SARO): EPS estimate not available, revenue estimate None

• Guardian Pharmacy Services (GRDN): EPS estimate not available, revenue estimate None

• Gemini Space Station Ltd (GEMI): EPS estimate not available, revenue estimate None

• Seaport Entertainment (SEG): EPS estimate not available, revenue estimate None

Be sure to check back daily for updates and insights into the earnings season and real-time results at Investing.com’s Earnings Calendar and Headlines. Do you want to trade the earnings of the biggest companies like a pro? Then get InvestingPro now and access over 1000 metrics that will give you a significant advantage in the shark tank that is Wall Street. Click here.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Risk Warnings and Disclaimers

Add to Favorites

Myomo to Report Third Quarter 2025 Financial Results on November 10

Dow Jones Newswires

Myomo

+3.65%

BURLINGTON, Mass.--(BUSINESS WIRE)--November 03, 2025--

Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the third quarter of 2025 on Monday, November 10, 2025. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions.

Participants are encouraged to pre-register for the conference call using this link to receive a dial-in number and PIN to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those unable to pre-register can participate by dialing 844-707-6932 (U.S.) or 412-317-9250 (International). A webcast of the call can be accessed at https://ir.myomo.com/.

A replay of the webcast will be available beginning approximately one hour after the completion of the live conference call at https://ir.myomo.com/. A dial-in replay of the call will be available until November 24, 2025 at 855-669-9658 (U.S. and Canada toll free), or 412-317-0088 (International toll), using access code 4112515.

About Myomo, Inc.

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. It is currently the only marketed device in the U.S. that, sensing a patient's own EMG signals through non-invasive sensors on the arm, can restore an individual's ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Burlington, Massachusetts, with sales and clinical professionals across the U.S and representatives internationally. For more information, please visit www.myomo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251103982522/en/

CONTACT: Myomo:

ir@myomo.com

Alliance Advisors IR:

Tirth T. Patel

tpatel@allianceadvisors.com

212-201-6614

Risk Warnings and Disclaimers

Add to Favorites